BBIO vs CLOV
BridgeBio Pharma Inc (BBIO) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BBIO currently screens at market cap $13.24B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BBIO and CLOV stock pages for the full models.
Not investment advice.